Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence

Category Primary study
JournalNeurology and Therapy
Year 2021
This article has no abstract
Epistemonikos ID: eaf7f784f67bd2cecabc4986e706707a4c910813
First added on: Feb 13, 2025